English | Español

Abbott Laboratories
Patient Daily Report | May 22, 2023

Dr. Lakkireddy: 'Assert-IQ ICM is a significant advancement amongst the tools that are currently available for diagnoses of irregular heart rhythms'
Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Press release submission | Oct 18, 2018

ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care
Marian Johns | Nov 17, 2017

Abbott receives approval in Japan for device to treat mitral regurgitation heart disease
Carol Ostrow | Nov 3, 2017

XIENCE implants show benefits in cardiac recovery
Mark Iandolo | Oct 26, 2017

Abbott rolls out new DRG Neurostimulator System to help combat chronic pain
Kathy Adams | Oct 6, 2017

Abbott completes acquisition of Alere
Carol Ostrow | Oct 3, 2017

Freestyle Libre gains FDA approval, ending need to prick finger for glucose testing, Abbott says

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program